AMOYTOP(SH:688278) Zheng Quan Zhi Xing·2025-03-27 12:27Core Viewpoint - The internal control evaluation report of Xiamen Te Bao Biological Engineering Co., Ltd. indicates that the company has maintained effective internal controls over financial reporting and has not identified any significant deficiencies in both financial and non-financial reporting as of the evaluation date [1][2]. Internal Control Evaluation Conclusion - The company confirmed that there are no significant deficiencies in financial reporting internal controls as of the evaluation date [2]. - The company also reported no significant deficiencies in non-financial reporting internal controls [2]. - No factors affecting the effectiveness of internal control evaluations have occurred between the evaluation date and the report issuance date [2]. Internal Control Evaluation Work Situation - The evaluation covered 100% of the total assets and total revenue of the company, ensuring comprehensive assessment across various business areas including governance, sales, procurement, production, quality management, asset management, R&D, investment management, and internal auditing [2]. - The company utilized a risk-oriented approach to determine the scope of the evaluation [2]. Internal Control Deficiency Recognition and Rectification - The company has established quantitative and qualitative standards for recognizing deficiencies in financial reporting internal controls, with specific thresholds for major, important, and general deficiencies [3][5]. - All identified general deficiencies have been rectified by the responsible departments and personnel by the end of the reporting period [6][7]. Other Internal Control Related Major Matters - The company is focused on enhancing internal control management capabilities and ensuring stable development through process improvement and management transformation [8].